Frigate Ventures »

Atrium Therapeutics shares owned by Frigate Ventures

Quarter-by-quarter ownership of Atrium Therapeutics (RNA) shares owned by Frigate Ventures from 13F filings

Historical chart of Frigate Ventures investment in Atrium Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Atrium Therapeutics held by Frigate Ventures consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atrium Therapeutics by Frigate Ventures

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.7M 125k 13.45

More positions owned by Frigate Ventures

Invesco QQQ Trust Series 1 Option Put Option (QQQ)
SELLAS Life Sciences Group Equity (SLS)
AdvisorShares Pure US Cannabis ETF Exchange Traded Fund (MSOS)
Lionsgate Studios Corp Option Call Option (LION)
iShares MSCI Canada ETF Option Put Option (EWC)
Match Group Equity (MTCH)
Five9 Equity (FIVN)
SPS Commerce Equity (SPSC)
Nvidia Corp Equity (NVDA)
Sunshine Silver Mining & Refining Equity
New America Acquisition I Corp Equity Unit (NWAX.U)
SanDisk Option Put Option (SNDK)
FutureCrest Acquisition Corp Equity Unit (FCRS.U)
Gildan Activewear Equity (GIL)
iShares 20 Year Treasury Bond ETF Option Call Option (TLT)

View all positions for Frigate Ventures

Top funds holding Atrium Therapeutics

T. Rowe Price Associates
Sessa Capital IM
BlackRock
Susquehanna International
Vanguard Capital Management
CRCM
TIG Advisors
Geode Capital Management
Two Sigma Investments
Goldman Sachs Group
683 Capital Management
Fort Hoosac Management
State Street Corporation
Cantor Fitzgerald, L. P.
Slotnik Capital

View all funds holding Atrium Therapeutics